Community Shares | July 15th 2024
This week’s articles: The recent U.S. Supreme Court ruling in Loper Bright Enterprises v. Raimondo, which overturned the 1984 Chevron precedent, may significantly impact the rights of people with disabilities; New research has highlighted the potential of using a combination of biomarkers to improve the diagnosis and understanding of ASD; A brief research report article has highlighted the connection between maternal autoantibodies (MAR-ABs) and increased inflammation during pregnancy, which may contribute to a higher risk of autism in their children;A recent study has identified brain energy metabolism dysfunction, marked by altered pH and lactate levels, as a common trait in various animal models of neuropsychiatric and neurodegenerative disorders, including autism spectrum disorders (ASD), schizophrenia, bipolar disorder, depression, and Alzheimer’s disease.
Cerebral Lactate Levels Higher in Adults with Autism than Neurotypical Controls
New German research has investigated cerebral lactate (Lac+) levels in high-functioning adults with Autism Spectrum Disorder (ASD) using Magnetic Resonance Spectroscopy (MRS), targeting the posterior cingulate cortex (PCC) as a potential biomarker for mitochondrial dysfunction.
Prenatal Contact with Organophosphates and Organochlorine Associated with ASD-Like Behaviors in Children
A new systematic review has examined the relationship between autism spectrum disorder (ASD) and pesticide exposure, considering both human and preclinical studies. This review included 45 human studies and 16 preclinical studies, focusing on various pesticide types like Organophosphates (OP), Organochlorine (OC), Pyrethroid (PT), Neonicotinoid (NN), Carbamate (CM), and mixed exposures.
